chr13-110473400-C-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001846.4(COL4A2):c.2425+250C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0347 in 469,094 control chromosomes in the GnomAD database, including 1,452 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.071 ( 1156 hom., cov: 33)
Exomes 𝑓: 0.017 ( 296 hom. )
Consequence
COL4A2
NM_001846.4 intron
NM_001846.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.347
Publications
3 publications found
Genes affected
COL4A2 (HGNC:2203): (collagen type IV alpha 2 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. The C-terminal portion of the protein, known as canstatin, is an inhibitor of angiogenesis and tumor growth. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jul 2008]
COL4A2 Gene-Disease associations (from GenCC):
- porencephaly 2Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- COL4A1 or COL4A2-related cerebral small vessel diseaseInheritance: AD Classification: MODERATE Submitted by: Illumina
- familial porencephalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 13-110473400-C-A is Benign according to our data. Variant chr13-110473400-C-A is described in ClinVar as Benign. ClinVar VariationId is 1270352.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.225 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL4A2 | NM_001846.4 | c.2425+250C>A | intron_variant | Intron 29 of 47 | ENST00000360467.7 | NP_001837.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0705 AC: 10723AN: 152142Hom.: 1150 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
10723
AN:
152142
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0175 AC: 5533AN: 316834Hom.: 296 AF XY: 0.0183 AC XY: 2993AN XY: 163788 show subpopulations
GnomAD4 exome
AF:
AC:
5533
AN:
316834
Hom.:
AF XY:
AC XY:
2993
AN XY:
163788
show subpopulations
African (AFR)
AF:
AC:
1721
AN:
7486
American (AMR)
AF:
AC:
205
AN:
10234
Ashkenazi Jewish (ASJ)
AF:
AC:
179
AN:
10770
East Asian (EAS)
AF:
AC:
1218
AN:
22088
South Asian (SAS)
AF:
AC:
1379
AN:
22400
European-Finnish (FIN)
AF:
AC:
4
AN:
23764
Middle Eastern (MID)
AF:
AC:
23
AN:
1542
European-Non Finnish (NFE)
AF:
AC:
285
AN:
198688
Other (OTH)
AF:
AC:
519
AN:
19862
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
227
454
682
909
1136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0707 AC: 10758AN: 152260Hom.: 1156 Cov.: 33 AF XY: 0.0681 AC XY: 5072AN XY: 74464 show subpopulations
GnomAD4 genome
AF:
AC:
10758
AN:
152260
Hom.:
Cov.:
33
AF XY:
AC XY:
5072
AN XY:
74464
show subpopulations
African (AFR)
AF:
AC:
9487
AN:
41508
American (AMR)
AF:
AC:
455
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
59
AN:
3470
East Asian (EAS)
AF:
AC:
190
AN:
5178
South Asian (SAS)
AF:
AC:
340
AN:
4828
European-Finnish (FIN)
AF:
AC:
2
AN:
10624
Middle Eastern (MID)
AF:
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
AC:
109
AN:
68032
Other (OTH)
AF:
AC:
112
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
424
848
1273
1697
2121
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
263
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.